At Cerveau Technologies we’re working towards the vision of globally developing diagnostics and technology in partnership with Enigma Biomedical Group and Sinotau Pharmaceutical Group. In turn, these developments can have a profoundly positive impact on patients suffering from neurodegenerative disorders, like Alzheimer’s disease. On June 22, Cerveau Technologies has signed an exciting agreement, one with …
Monthly Archives: September 2018
Enigma Biomedical Group and Invicro Sign a Collaboration Agreement
At Enigma Biomedical group, we’re focused on molecular imaging and medicine. We’re on a mission to progress developmental studies in brain health and accelerate them by offering an array of services, so that they’re able to impact the world on a vast, global scale. From vaccine development to the revolution of genomics, we’re here …
Continue reading “Enigma Biomedical Group and Invicro Sign a Collaboration Agreement”